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ABSTRACT
Previous studies have shown that tolerance develops to a greater degree in male 
compared to female rats. The midbrain periaqueductal gray (PAG), and its descending 
projections to the rostral ventromedial medulla (RVM), provides an essential neural 
circuit for the antinociceptive effects of opiates and has been implicated in the 
development of tolerance to morphine. We have previously reported that systemic 
morphine administration activates a greater proportion of PAG-RVM neurons in male 
versus female rats; our hypothesis is that if the PAG-RVM pathway is essential for the 
development of morphine tolerance, then (1) morphine activation of the PAG-RVM 
pathway should decline as tolerance develops, and (2) sex differences should be 
reflected as a greater decline in males. These hypotheses were tested using behavioral 
and neuroanatomical techniques to map the activation of the PAG-RVM pathway during 
the development of tolerance to repeated morphine administration (4.5 mg/kg; s.c.). We 
found that as male rats develop tolerance (D50 increased from 3.0 to 6.3 mg/kg), there 
was no significant decline in the overall activation of the PAG, however, there was a 
steady decline in the percentage of PAG-RVM output neurons activated by morphine. 
This reduction occurred in males only; there was no significant decline in the activity of 
PAG-RVM output neurons in females. These data demonstrate that the greater 
development of tolerance to morphine administration in male rats corresponds with a 
significant reduction in the activation of the PAG-RVM circuit. Our results provide 
additional data demonstrating a central role for the PAG in morphine tolerance.
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INTRODUCTION
It is estimated that as many as one in five adults currently experience chronic 
pain.  Of that population, 41% are receiving treatment with opioid-based narcotics 
(Breivik et al., 2006).  While morphine and other opioid-based narcotics are the most 
effective treatment for pain, opiates do not provide adequate pain relief for many 
people. The sex of the patient and the development of tolerance to morphine’s 
analgesic effects are two particularly important factors that limit the effectiveness of 
opiates.  Men tend to experience greater analgesia following opiate administration 
compared to women (Cepeda & Carr, 2003; Miller & Ernst, 2004), a difference that has 
been reported for a wide range of other species using both somatic and visceral pain 
models (Craft, 2003; Ji et al., 2006; Loyd & Murphy, 2006; Wang et al., 2006; Loyd et 
al., 2007).  
Recent findings suggest that the midbrain periaqueductal gray (PAG), and its 
descending projections to the rostral ventromedial medulla (RVM), contribute to the 
sexually dimorphic actions of morphine. Microinjection of morphine directly into the PAG 
produces greater antinociception in male compared to female rats (Krzanowska & 
Bodnar, 1999; Wang et al., submitted), and blocking PAG opioid receptors reduces 
morphine antinociception to a greater extent in female rats (Bernal et al., 2007). 
Furthermore, both the anatomy and physiology of the PAG-RVM pathway is sexually 
dimorphic, with males having a significantly greater percentage of PAG-RVM neurons 
activated by either inflammatory pain (Loyd & Murphy, 2006) or systemic morphine 
(Loyd et al., 2007).
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Tolerance is known to occur with repeated or continuous administration of 
morphine into the ventrolateral PAG of male rats (Jacquet & Lajtha, 1976; Siuciak & 
Advokat, 1987; Tortorici et al., 1999; Tortorici & Morgan, 2002; Lane et al., 2005; 
Morgan et al., 2006). In addition, blocking opioid binding in the ventrolateral PAG 
attenuates tolerance to systemically administered morphine (Lane et al., 2005). 
Tolerance appears to be mediated by a reduction in mu opioid receptor signaling 
efficacy in PAG neurons (Bagley et al., 2005), an effect that is reversed when mu opioid 
receptor coupling is enhanced via upregulated cyclase activity (Hack et al., 2003). 
These findings suggest that the PAG contributes to the decrease in antinociception that 
occurs with the development of tolerance.
Given that morphine activates a greater percentage of PAG-RVM output neurons 
in male compared to female rats (Loyd et al., 2007), our working hypothesis is that if the 
PAG-RVM pathway is essential for the development of morphine tolerance, then (1) 
activation of the PAG-RVM pathway should decline as tolerance to repeated injections 
of systemic morphine develops, and given that males show greater antinociception and 
greater tolerance (Craft et al., 1999; Barrett et al., 2001), (2) sex differences should be 
reflected as a greater decline in the activation of the PAG-RVM pathway in male 
compared to female rats. These hypotheses were tested using behavioral assessment 
of nociception and neuroanatomical techniques to map the activation of the PAG-RVM 
pathway over the time course of the development of tolerance to repeated morphine 
administration. 
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MATERIALS AND METHODS
Experimental Subjects
Thirty-five adult male and thirty-seven weight-matched (250-350g) cycling female 
Sprague-Dawley rats were used in these experiments (behavior subjects from Harlan, 
Indianapolis, IN and anatomy subjects from Zivic-Miller; Pittsburg, PA). Rats were 
housed in same-sex pairs on a 12:12 hour light: dark cycle.  Access to food and water 
was ad libitum throughout the experiment except during surgery and testing. These 
studies were performed in compliance with the Institutional Animal Care and Use 
Committees at Georgia State University and at Washington State University. All efforts 
were made to minimize any possible suffering by the animal, and to reduce the number 
of animals used.
Experiment 1: Behavioral Assessment of Morphine Tolerance
Thirteen male and fourteen female rats were handled daily for five days prior to 
initiation of drug administration. Morphine sulfate (5 mg/kg; provided by the National 
Institute on Drug Abuse, Bethesda, MD; Loyd et al., 2007) was prepared in a saline 
vehicle and administered systemically twice a day for thr e consecutive days to male 
(n=7) and female (n=7) rats. Control groups consisting of six male and seven female 
rats received daily injections of saline (1 ml/kg, s.c.).  Tolerance was assessed on Day 4 
by injecting cumulative doses of morphine every 20 minutes resulting in quarter log 
doses of 1.8, 3.2, 5.6, 10.0, and 18.0 mg/kg.  Nociception was assessed using the hot-
plate test 15 minutes after each injection.  The hot plate test measures the latency to 
lick the hindpaw when the rat is placed on a 52.5oC plate.  If the animal did not respond 
within 50 seconds, it was removed from the plate and given a score of 50 seconds.  The 
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mean latency at each dose was calculated for male and female rats pretreated with 
morphine or saline. 
Behavioral Data Analysis and Presentation
The half-maximal antinociceptive effect (D50; Tallarida, 2000) and 95% 
confidence intervals (CI) were calculated from dose-response curves generated using 
GraphPad software. The lower limit for calculating D50 values was the mean baseline 
score, and the upper limit was the mean hot plate latency following administration of the 
highest morphine dose. Changes in D50 between groups were assessed using ANOVA 
(GraphPad).
Experiment 2: Anatomical Assessment of Morphine Tolerance
     Retrograde Tracer Injections
Twenty-two male and twenty-three female rats were deeply anesthetized with 
ketamine/xylazine (50 mg/kg / 10mg/kg; s.c.).  When a surgical plane of anesthesia was 
reached each animal was placed in a stereotaxic frame and the skull was adjusted so 
bregma and lambda were at the same dorsal-ventral plane.  Glass micropipettes (10-20 
µM) filled with the retrograde tracer Fluorogold (FG; 2% soln. w/v in saline;
Fluorochrome LLC; Denver, CO) were lowered into the RVM using the following 
coordinates (in mm): AP: -2.0 Lambda; ML: 0.0; DV: -8.5).  FG was iontophoresed 
(50/50 duty cycle, 7.5 µA current) into the RVM for 25 minutes to facilitate neuronal 
uptake.  The current was then turned off and the pipettes remained in place for an 
additional 5 minutes prior to removal to minimize backflow of the tracer along the pipette 
track. Following tracer injections, wounds were sutured closed, the antibiotic Neosporin 
was applied to the wound, and the animals were placed in clean cages to recover under 
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a heat lamp.   Upon complete recovery from the anesthetic, animals were returned to 
their original housing facilities.
     Morphine Administration
Ten days following tracer injection, animals were administered morphine or 
saline for three consecutive days.  Morphine sulfate was prepared fresh in a saline 
vehicle within one hour prior to administration. Animals were divided into two 
experimental groups: (1) eight male and eight female rats received one daily injection of 
morphine sulfate (4.5 mg/kg, s.c.; NIDA; Bethesda, MD) for three consecutive days and 
(2) five male and six female rats received two daily injections of morphine sulfate for 
three consecutive days. Injections were administered between the hours of 10:00A.M. 
and 4:00P.M. with multiple daily injections separated by six hours.  Two control groups 
were used: (3) the morphine naïve group consisted of four male and four female rats 
injected with saline twice daily for three consecutive days and (4) the acute morphine 
group consisted of five male and five female rats injected with saline twice daily for 2.5 
consecutive days followed by a final injection of morphine (see Table 1).
     Perfusion fixation
One hour following the last injection of morphine or saline, all animals were given 
a lethal dose of Nembutal (160 mg/kg; i.p.). The animals were transcardially perfused 
with 200-250 ml of 0.9% sodium chloride containing 2% sodium nitrite as a vasodilator 
to remove blood from the brain. Immediately following removal of blood, 300 ml of 4% 
paraformaldehyde in 0.1M phosphate buffer containing 2.5% acrolein (Polyscience; 
Niles, IL) was perfused through the brain as a fixative. A final rinse with 200-250 ml of 
the sodium chloride/sodium nitrate solution was perfused through the brain to remove 
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any residual acrolein. Immediately following perfusion, the brains were carefully 
removed, placed in a 30% sucrose solution and stored at 40C for at least one week prior 
to sectioning. Sucrose solutions were changed daily to optimize saturation of sucrose 
into the tissue. To section the brain, the dura and pia matter were carefully removed and 
the brains were cut into six series of 25 µm coronal sections with a Leica 2000R 
freezing microtome and stored free-floating in cryoprotectant-antifreeze solution 
(Watson et al., 1986) at –20oC until immunocytochemical processing.
      Immunocytochemistry
A 1:6 series through the rostrocaudal axis of each brain was processed for FG 
and Fos immunoreactivity as previously described (Murphy & Hoffman, 2001). Briefly, 
sections were rinsed extensively in potassium phosphate-buffered saline (KPBS) to 
remove cryoprotectant solution immediately followed by a 20-minute incubation in 1% 
sodium borohydride to remove excess aldehydes.  The tissue was then incubated in 
primary antibody solution rabbit anti-Fos (Oncog ne; Cambridge, MA, lot no. 4194; 
1:50,000) in KPBS containing 1.0% Triton-X for one hour at room temperature followed 
by 48 hours at 4°C. After rinsing out the primary antibody with KPBS, the tissue was 
incubated for one hour in biotinylated goat anti-rabbit IgG (Jackson Immunoresearch; 
West Grove, PA, 1:200), rinsed with KPBS, followed by a one hour incubation in avidin-
biotin peroxidase complex (1:10; ABC Elite Kit, Vector Labs). After rinsing in KPBS and 
sodium acetate (0.175 M; pH 6.5), Fos was visualized as a black reaction product using 
nickel sulfate intensified 3,3’-diaminobenzidine solution containing 0.08% hydrogen 
peroxide in sodium acetate buffer. After rinsing, sections were placed in primary 
antibody solution rabbit anti-FG (Chemicon; Billerica, MA, lot no. 25060005; 1:10,000) in 
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KPBS containing 1.0% Triton-X for one hour at room temperature followed by 48 hours 
at 4°C. FG was visualized as a brown reaction product using 3,3’-diaminobenzidine 
containing 0.08% hydrogen peroxide in Trizma buffer (pH 7.2). After 15-30 minutes, 
three rinses in sodium acetate buffer terminated the reaction. Sections were then 
mounted out of saline onto gelatin-subbed slides, air-dried overnight, dehydrated in a 
series of graded alcohols, cleared in xylene, and cover-slipped using Permount.
    Anatomical Data Analysis and Presentation
Data were analyzed across six representative levels through the rostrocaudal
axis of the PAG (Bregma -6.72, -7.04, -7.74, -8.00, -8.30, -8.80). The number of PAG-
RVM output neurons (FG+), the total number of activated PAG neurons (Fos+), and the 
number of activated PAG-RVM output neurons (Fos+FG) were quantified. Cell counts 
were conducted unilaterally as there are no differences in the number of FG+ cells for 
the left versus right side of PAG (Loyd & Murphy, 2006). The tissue was sectioned at 25 
µm so that 125 µm separates each analyzed level of the PAG thus eliminating any 
possible bias from counting the same cell twice.  Additionally, previous data have shown 
that there are no sex differences in total area (mm2) of the PAG between weight-
matched male and female Sprague-Dawley rats (Loyd & Murphy, 2006). 
Data are expressed as the mean + standard error of the mean from which 
percentages were calculated. A three-way analysis of variance (ANOVA) was used to 
test for significant main effects of sex (male, female), PAG level (Bregma –6.72 through 
-8.80) and treatment (two experimental groups of morphine administration and two 
control groups). A one-way ANOVA was used for post-hoc analysis to test for significant 
main effects of treatment and the Fishers PLSD was used to determine significant 
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interactions between treatment groups when there was a significant main effect 
independent of sex. P<0.05 was considered significant for all analyses. 
Photomicrographs were generated using a Synsys digital camera attached to a 
Nikon Eclipse E800 microscope.  Images were captured with IP Spectrum software, 
adjusted to figure format by adjusting brightness and contrast levels using Adobe 
Photoshop 7.0. 
RESULTS 
Experiment 1: Behavioral Assessment of Morphine Tolerance
The objective of the present experiment was to compare the development of 
tolerance to morphine in male and female rats. Animals received daily morphine or 
saline injections for three days. On day 4, all animals received cumulative doses of 
morphine and tolerance was examined in each group using the hot-plate latency test. 
Administration of morphine on the day of testing produced a dose-dependent increase 
in hot-plate latency in all groups tested (Figure 1). The antinociceptive potency of 
morphine was greatest in male rats pretreated with salin  on days 1-3 (D50 = 3.0 
mg/kg). In contrast, the D50 for female rats pretreated with saline was 6.1 mg/kg, a 2.0 
fold increase when compared to males. Consistent with the development of tolerance, 
male rats pretreated with morphine showed a significant rightward shift in the morphine 
dose-response curve compared to male rats pretreated with saline ([F(1,74) = 20.04, p
< .001]; Figure 1A).  Specifically, the D50 increased from 3.0 mg/kg (CI = 2.2 – 3.7) to 
6.3 mg/kg (CI = 5.1 – 7.6) in rats pretreated with morphine, a 2.1 fold shift in the D50. 
By contrast, female rats showed significantly less tolerance compared to the male rats. 
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In females, pretreatment with morphine on days 1-3 resulted in a small rightward shift 
[F(1,115) – 5.63; p < .05] in the dose-response curve from 6.1 mg/kg (CI = 5.2 – 7.0) to 
8.0 mg/kg (CI = 6.6 – 9.4; Figure 1B) indicating that females were much less sensitive to 
morphine tolerance.
Experiment 2a: Anatomical Assessment of Morphine Tolerance in the PAG
The next series of experiments were conducted to determine if there is a 
corresponding decrease in the activation of the PAG-RVM pathway during the 
development of tolerance to repeated systemic morphine administration in male and 
female rats. Animals were administered either one daily injection of morphine for three 
consecutive days (three doses total) or two daily injections of morphine for three 
consecutive days (six doses total). Control groups consisted of either two daily 
injections of saline for three consecutive days (saline only) or two daily injections of 
saline for two days and on the third day received one injection of saline followed by one 
injection of morphine (one dose total; See Table 1). All animals were perfused one hour 
following the last dose of morphine or saline and their brains were processed for Fos 
and FG immunoreactivity.
Across all groups, systemic morphine administration induced extensive Fos 
expression throughout the rostrocaudal axis of the PAG. Fos was evident in both 
intrinsic (non-FG+) PAG neurons and in PAG-RVM (FG+) output neurons. No significant 
main effect of sex [F(1,208)= .764, p>0.05] or PAG level [F(5,208)= .0454, p>0.05] was 
noted in the mean number of morphine-induced Fos in PAG neurons. However, there 
was a significant main effect of treatment [F(3,208)= 8.733, p<0.05] and a significant 
sex-by-treatment interaction [F(3,208)= 10.617, p<0.05]. Across all levels of the PAG, 
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male rats treated with saline generally had significantly less Fos expression compared 
to all other treatment groups (Figure 2, p<0.05). In females, administration of one dose 
of morphine resulted in significantly less Fos expression than females treated with 
saline only (Figure 2, p<0.05). Total Fos expression was comparable between the three 
morphine treatment groups.
Experiment 2b: Anatomical Assessment of Morphine Tolerance in the PAG-RVM Circuit
Figure 3 shows an example of a typical iontophoretic injection of FG into the 
RVM of a male (top) and female (bottom) rat.  All injections were located on the midline 
and dorsal to the pyramidal tract, at the level of the caudal pole of the facial nucleus 
(lambda –2.0mm).  Injections outside of the RVM were not included for analysis.  
Injection of FG into the RVM produced dense retrograde labeling throughout the 
rostrocaudal axis of the PAG, with females having a significantly greater amount of 
labeling compared to males [F(1,208)=59.610, p<0.05] (data not shown; Loyd et al, 
2006, Loyd et al., 2007). 
Administration of one dose of morphine resulted in extensive Fos expression in 
PAG-RVM output neurons across all rostrocaudal levels of the PAG in male but not 
female rats (Figure 4).  An analysis of the %Fos in FG+ cells revealed a significant main 
effect of sex [F(1,208)= 41.194, p<0.05], treatment [F(3,208)= 43.607, p<0.05] and a 
significant sex by treatment interaction [F(3,208)= 19.440, p<0.05]. There was no 
significant main effect of PAG level [F(5,208)= .1883, p>0.05] indicating that these 
results were consistent across the rostrocaudal axis of the PAG. The %Fos in FG 
neurons decreased as a function of morphine treatment in males only [F(2,71)= 26.546, 
p<0.05]. Overall, the average %Fos in FG neurons decreased from 44±6% in males 
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receiving one injection of morphine to 8±2% in males following the sixth injection of 
morphine. In females, the %Fos in FG cells was low across all rostrocaudal levels of the 
PAG and no significant effect of treatment was observed [F(2,83)= 1.919, p>0.05]. 
Overall, the average %Fos in FG cells decreased non-significantly from 22±4% in 
females receiving one dose of morphine to 8±2% in females receiving six doses of 
morphine. Together, these results parallel our behavioral data indicating greater 
development of tolerance in male rats.
DISCUSSION
In the present study, behavioral and neuroanatomical techniques were used to 
examine the role of the PAG-RVM circuit in the development of tolerance to systemic 
morphine in male and female rats. The results demonstrate that repeated administration 
of systemic morphine induces tolerance in male to a much greater extent than in female 
rats. In parallel, repeated morphine administration significantly reduces the activation of 
PAG-RVM neurons in males but not females. The effective dose for antinociception in 
saline treated animals was two times greater for female compared to male rats and is 
consistent with previous research (Cicero et al., 1997; Cook & Nickerson, 2005; Ji et al., 
2006; Wang et al., 2006). Sex differences in morphine potency are reflected in the 
greater activation of PAG-RVM output neurons in males following morphine 
administration reported here and previously (Loyd et al., 2007). In addition, the greater 
tolerance to morphine in male compared to female rats is also consistent with previous 
research (Barrett et al., 2001; Bernal et al., 2007). Our data show that two injections of 
morphine per day for three consecutive days was sufficient to reduce morphine potency 
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by 2.1 times in male rats. However, in females, the half maximal effective dose of 
morphine only increased from 6.1 to 8.0 mg/kg. Thus, not only do female rats show less 
antinociception in response to morphine, but they also show much less tolerance to 
morphine.
Our data indicate that the PAG and its projections to the RVM likely contribute to 
the observed behavioral differences between male and female rats. Although there was 
no significant main effect of sex in the number of Fos+ neurons in the PAG observed 
following morphine administration, the number of Fos+ neurons in the PAG that were 
retrogradely labeled from the RVM following a single dose of morphine was greater in 
male compared to female rats. Moreover, a progressive decrease in the number of 
Fos+FG neurons occurred following three or six repeated injections of morphine in male 
rats. This decrease in activation of PAG-RVM output neurons in male rats led to 
Fos+FG expression that was comparable to female rats. Moreover, the limited 
antinociceptive tolerance in females was consistent with a lack of change in the 
percentage of Fos+FG neurons following one, three, or six repeated injections of 
morphine. These data correspond very closely with the b havioral data showing that 
morphine antinociception is greater in male compared to female rats and tolerance 
causes a reduction in morphine potency so that tolerant male rats experience 
comparable analgesia to non-tolerant female rats. These results demonstrate that the 
development of tolerance to morphine is associated with a reduction in the activation of 
the PAG-RVM circuit in male rats and provide additional data demonstrating a central 
role for the PAG in morphine tolerance.  
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It has been shown that tolerance occurs with repeated microinjections of morphine 
directly into the ventrolateral PAG (Morgan et al., 2006; Tortorici et al., 1999) and is 
associated with a reduction in mu opioid receptor signaling in the PAG (Bagley et al., 
2005). Importantly, blocking opioid binding in the PAG attenuates the development of 
tolerance (Lane et al., 2005). While the PAG does not project directly to the spinal cord, 
it projects heavily to the RVM as a relay to the spinal cord (Beitz, 1982; Beitz et al., 
1983).  The activity of RVM on-cells and off-cells that are normally inhibited and 
activated by morphine, respectively, become non-responsive to morphine following the 
induction of tolerance (Lane et al., 2004).  Given that tolerance develops to a greater 
degree when morphine is administered directly into the PAG compared to administration 
into the RVM (Morgan et al., 2005) and there is a corresponding progressive decrease 
in the activity of PAG-RVM neurons, these data together indicate that a key mechanism 
for tolerance resides within the PAG. Although several neural structures contribute to 
tolerance to the antinociceptive effects of morphine, the PAG appears to play a 
prominent role in the development of tolerance to systemic morphine administration.
Previous data have shown that systemic morphine administration induces 
extensive Fos expression in the PAG that is comparable in male and female rats (Loyd
et al., 2007). Similarly, in the present study, total Fos expression in the PAG was not 
sexually dimorphic.  However, unlike our previous study, morphine administration in 
males did not induce significantly greater Fos labeling compared to saline-treated rats. 
This difference between the effects of morphine in these two studies suggests that the 
multiple injections of saline over three days in the present study induces Fos expression 
that is independent of morphine. Given that Fos expression can be induced by a wide 
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range of stimuli including fear and anxiety (Kim et al., 1993), changes in respiration 
(Zhang et al., 1990; Harper et al., 1996), vocalization (Davis et al., 1993; Zhang et al., 
1994), blood pressure (Carrive, 1991; Murphy et al., 1995), and in fight or flight 
responses (Bandler et al., 1985; Bandler & Carrive, 1988; Depaulis et al., 1992), it is not 
surprising that repeated daily injections of saline induced Fos in PAG neurons. In 
contrast, PAG neurons retrogradely labeled with FG from the RVM were more likely to 
express Fos following morphine administration than saline treated rats. Moreover, this 
increase in Fos expression was greater in male compared to female rats. Both the 
increase in Fos+FG cells following morphine administration and the greater Fos labeling 
in male rats is consistent with our previous data (Loyd et al., 2007). The greater Fos 
expression in PAG-RVM neurons correlates with the greater morphine antinociception
produced in male compared to female rats. 
Sex differences in mu opioid receptor (MOR) distribution and function in the PAG 
(Duncan & Murphy, 2005) may provide a mechanism for sex differences in morphine 
tolerance. Furthermore, cells that express both MOR and GABA are common in the 
PAG (Williams & Beitz, 1990; Kalyuzhny & Wessendorf, 1998) suggesting that 
morphine directly modulates the GABAergic neurons that tonically inhibit PAG-RVM 
neurons (Behbehani & Fields, 1979; Chieng & Christie, 1994; Vaughan & Christie, 
1997; Commons et al., 2000; Tortorici & Morgan, 2002). Administration of GABA 
agonists hyperpolarize PAG-RVM neurons (Osborne et al., 1996) and microinjection of 
GABA antagonists into the PAG results in a net increase in membrane depolarization, 
firing frequency, frequency of EPSPs (Behbehani et al., 1990) and antinociception 
(Morgan et al. 2005). In the present study, a potential mechanism of action may be that 
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morphine is acting at mu opioid receptors present on GABA interneurons in the PAG. 
As tolerance develops, these GABAergic cells become unresponsive to morphine 
resulting in a return of tonic inhibition on PAG-RVM neurons and a corresponding 
decrease in the antinociceptive effects of morphine. This hypothesis is supported by the 
finding that repeated kainate-induced activation of PAG neurons is not sufficient to 
produce tolerance (Morgan et al., 2003). 
 The PAG also contains a high density of estrogen (ER) receptors (Murphy & 
Hoffman, 1999; Murphy & Hoffman, 2001; Marson & Murphy, 2006) and approximately 
25% of PAG-RVM neurons contain ER (Loyd and Murphy, unpublished observations). 
Estrogen has been shown to uncouple MOR from G protein-gated inwardly rectifying 
potassium channels, thus reducing morphine hyperpolarization of PAG-RVM neurons 
(Kelly et al., 2003).  In the present study, circulating estrogen acting at ER receptors 
may be rapidly uncoupling MOR in the PAG of female rats, resulting in an overall 
reduction in the activity of these cells, thus preventing the development of tolerance. 
Cycling females were used in these studies and all rats continued to cycle normally 
during the three consecutive days of morphine or saline administration.  The activation 
of PAG neurons in females tended to be more variable compared to males and stage of 
estrous may potentially affect morphine potency and tolerance. Interestingly, it has been 
shown that the excitability of neurons in the PAG is variable across the estrous cycle of 
the rat. During estrus and late diestrus, lower currents are required to stimulate PAG 
output neurons and GABA antagonists greatly increase PAG-RVM neuronal firing rates, 
suggesting a decrease in GABAergic tone (Brack & Lovick, 2007). 
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In summary, the results of the present study indicate that the tolerance to 
repeated systemic morphine injections occurs in male rats, but not female rats.  With 
repeated injections of morphine, the activation of the PAG-RVM pathway steadily 
declines such that males tolerant to the effects of morphine have a significantly reduced 
activation of the PAG-RVM pathway. Together, these data demonstrate that the 
development of tolerance to morphine is associated with a reduction in the activation of 
the PAG-RVM circuit in male rats only and provide additional data demonstrating a 
central role for the PAG in morphine tolerance.
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TITLES AND LEGENDS TO FIGURES 
Table 1. Dosing Schedule for Experimental and Control Groups in Experiment 2  
 
Figure 1. Comparison of tolerance to the antinociceptive effects of morphine in male (A) 
and female (B) rats. Rats were pretreated with morphine or saline twice a day for 
3 days (see figure legend for pretreatment). Morphine dose-response curves for 
antinociception on the hot plate (HP) test were generated on Day 4 using a 
cumulative dosing paradigm. Both antinociceptive potency and tolerance to 
morphine were reduced in female (B) compared to male (A) rats. 
 
Figure 2. A-F: Mean number of Fos-positive cells in male and female rats across the 
four experimental groups.  Rats were injected with either morphine or saline once 
or twice daily for three days. Fos labeling was measured across six rostrocaudal 
levels of the PAG one hour following the last injection. Saline: morphine naïve; 1 
Dose: saline pretreatment followed by one dose of morphine; 3 Doses: one dose 
of morphine per day; 6 Doses: two doses of morphine per day. Fos labeling did 
not vary across conditions or groups. 
 
Figure 3. Photomicrograph of representative examples of FG injection sites at the RVM 
of a male (top) and female (bottom) rat. Injection sites were limited to localization 
within the bottom third of the medulla along the midline between the facial nuclei 
and dorsal to the pyramidal tract. Gi: gigantocellularis; py: pyramidal tract; 4V: 
fourth ventricle; 7: facial nucleus. 
 
Figure 4. A-F: Percentage of Fos-positive neurons that were retrogradely labeled from 
the RVM (%Fos/FG) in male (solid bars) and female (open bars) rats for six 
rostrocaudal levels of the PAG. Saline: morphine naïve; 1 Dose: saline 
pretreatment followed by one dose of morphine; 3 Doses: one dose of morphine 
per day; 6 Doses: two doses of morphine per day. A decrease in labeling is 
evident with an increase in the number of morphine injections for male rats as 
would be expected with the development of tolerance. In contrast, activation of 
output neurons was relatively low in female rats regardless of the number of 
morphine injections. 
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